首页 | 本学科首页   官方微博 | 高级检索  
     

乳腺癌组织HR与HER-2和SATB1表达相关性研究
引用本文:崔霞,王婧男,郑燕,孙玉萍,汪运山. 乳腺癌组织HR与HER-2和SATB1表达相关性研究[J]. 齐鲁肿瘤杂志, 2014, 0(12): 885-889
作者姓名:崔霞  王婧男  郑燕  孙玉萍  汪运山
作者单位:[1]山东大学附属济南市中心医院肿瘤科,山东济南250013 [2]山东大学附属济南市中心医院中心实验室,山东济南250013 [3]山东中医药大学附属医院检验科,山东济南250011
基金项目:国家自然科学基金(81000869);山东省优秀中青年科学家科研奖励基金(BS2011YY039)
摘    要:目的:检测乳腺癌组织中激素受体(hormonereceptor,HR)、人表皮生长因子受体2(humanepidermalgrowthfactOrreceptor2,HER-2)和特异性核基质结合蛋白(specialATrichsequencebindingprotein1,SATB1)的表达,探讨HR与HER-2、SATB1及临床病理参数的关系。方法:应用免疫组织化学方法检测乳腺癌患者雌激素受体(estrogenre-ceptor,ER)、孕激素受体(progesteronereceptor,PR)、HER-2及SATB1蛋白的表达,荧光原位杂交方法检测HER-2基因扩增状态,统计学方法分析HR(包括ER及PR)的表达与HER-2、SATB1及临床病理参数之间的相关性。结果:乳腺癌组织ER及PR的表达均与患者年龄正相关(r=0.286,P=0.010;r=0.249,P=0.026),ER的表达与肿瘤分级负相关(r=-0.306,P=0.006);ER及PR的表达与肿瘤大小、组织学类型、淋巴转移情况及TNM分期均无明显相关性,P值均〉0.05。HR的表达与SATB1、HER-2及SATB1/HER2双阳性表达均呈负相关关系(r=-0.248,P=0.027;r=-0.392,P〈0.001;r=-0.150,P〈0.001)。结论:HR阳性患者治疗及预后相对较好;乳腺癌组织HR的表达与HER-2和SATB1呈负相关关系,三者之间可能存在相互联系的信号通路。

关 键 词:乳腺肿瘤  激素受体  雌激素受体  孕激素受体  SATB1蛋白  HER-2蛋白

Expression of HR and its correlations with HER-2 and SATB1 in breast cancer tissues
Affiliation:CUIXia ,WANG Jing-nan ,ZHENG Yan ,SUN Yu-ping ,WANG YuJi-shan(1. DeDartment of Ontology ,J iman Central HosDital Affiliated to Shandong Uni-oersity ,Jinan 250013, P. R. China 2. DeDartment of Laboratory ,Affiliated HosDital of Shandong University of Traditional Chinese Medicine, J inan 250011 ,P. R. China)
Abstract:OBJECTIVE:To detect the expression of hormone receptor (HR) ,human epidermal growth faclor recep tor 2 (HER 2) and specific nuclear matrix binding protein I(SATB1) in breast cancer,and explore the correlations be tween HR and HEP- 2,SATB1 as well as the elinicopathological features. METHODS: Immunohistoehemistry was used to detect the expression of estrogen receptor (ER), progesterone receptor (PR), HER 2 and SATB1 protein in breast cancer patients. FISH was used to test the amplification of HER-2 gene. Correlations of HR with HER-2, SATB1 and clinicopathologic features were analyzed. RESULTS: The expression of ER, PR was positively correlated with patient age in breast cancer(r=0. 286, P= 0. 010;r= 0. 249,P 0. 026), while ER expression was negatively correlated with tumor grade(r=-0. 306, P = 0. 006). No correlations were found between ER or PR expression and tumour size, pathological type,lymph node status as well as TNM stage (All P〈0.05). HR expression was negatively correlated with HER-2, SATB1 expression and SATB1/HER-2 co-expression(r= 0.248,P=0.027;r=-0.392,P〈0.001;r=-0.450,P〈 0. 001). CONCLUSIONS: HR positive expression may indicate a better therapitic and prognostic outcome. Negative correlations existed between the expression of HR and SATB1/HER 2 in breast cancer tissues; and the phenomenon possibly suggested their cross-talks though the signaling pathways.
Keywords:bresat carcinoma  hormone receptor  estrogen receptor  progesterone receptor  special AT rich sequencebinding protein 1h  uman epidermal growth factor receptor 2
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号